HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial.
Saved in:
| Title: | HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. |
|---|---|
| Authors: | Li SH; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong, China., Zuo ZJ; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China., Lu LH; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China., Xu LZ; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China., Wang QX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Zhao RC; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China., Mei J; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China., Li JB; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Clinical Research Methodology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Zheng L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.; Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Guo RP; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. guorp@sysucc.org.cn.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. guorp@sysucc.org.cn., Wei W; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. weiwei@sysucc.org.cn.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. weiwei@sysucc.org.cn.; Department of Hepatopancreatobiliary Surgery, Gansu Hospital of Sun Yat-sen University Cancer Center, Lanzhou, Gansu, China. weiwei@sysucc.org.cn. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 15; Vol. 11 (1). Date of Electronic Publication: 2026 May 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2059-3635 |
|---|---|
| DOI: | 10.1038/s41392-026-02718-0 |
